SI1345597T1 - Amfifilni lipidni nanodelci za vgradnjo peptidov in/ali proteinov - Google Patents
Amfifilni lipidni nanodelci za vgradnjo peptidov in/ali proteinovInfo
- Publication number
- SI1345597T1 SI1345597T1 SI200130782T SI200130782T SI1345597T1 SI 1345597 T1 SI1345597 T1 SI 1345597T1 SI 200130782 T SI200130782 T SI 200130782T SI 200130782 T SI200130782 T SI 200130782T SI 1345597 T1 SI1345597 T1 SI 1345597T1
- Authority
- SI
- Slovenia
- Prior art keywords
- peptide
- lipid nanoparticles
- amphiphilic lipid
- protein incorporation
- incorporation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00128555 | 2000-12-27 | ||
EP01125742 | 2001-10-26 | ||
EP01995691A EP1345597B1 (en) | 2000-12-27 | 2001-12-17 | Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
PCT/EP2001/014877 WO2002051390A2 (en) | 2000-12-27 | 2001-12-17 | Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1345597T1 true SI1345597T1 (sl) | 2007-12-31 |
Family
ID=26071689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130782T SI1345597T1 (sl) | 2000-12-27 | 2001-12-17 | Amfifilni lipidni nanodelci za vgradnjo peptidov in/ali proteinov |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040081688A1 (sl) |
EP (1) | EP1345597B1 (sl) |
JP (1) | JP4072057B2 (sl) |
AR (1) | AR032073A1 (sl) |
AT (1) | ATE374603T1 (sl) |
AU (1) | AU2002226374B2 (sl) |
CA (1) | CA2431888C (sl) |
CY (1) | CY1106995T1 (sl) |
DE (1) | DE60130791T2 (sl) |
DK (1) | DK1345597T3 (sl) |
ES (1) | ES2291379T3 (sl) |
IL (2) | IL156531A0 (sl) |
PT (1) | PT1345597E (sl) |
SI (1) | SI1345597T1 (sl) |
WO (1) | WO2002051390A2 (sl) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050208083A1 (en) | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
CA2528095C (en) * | 2003-06-04 | 2014-10-14 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
CA2541445A1 (en) * | 2003-10-31 | 2005-05-12 | Teva Pharmaceutical Industries Ltd. | Nanoparticles for drug delivery |
JP3903061B2 (ja) * | 2003-12-24 | 2007-04-11 | 株式会社Lttバイオファーマ | 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤 |
FR2868704B1 (fr) * | 2004-04-07 | 2007-09-14 | Ethypharm Sa | Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires |
WO2008010788A2 (en) | 2005-07-18 | 2008-01-24 | University Of Massachusetts Lowell | Compositions and methods for making and using nanoemulsions |
WO2008051186A2 (en) * | 2005-08-09 | 2008-05-02 | Nanobio Corporation | Nanoemulsion containing compositions having ant i -inflammatory activity |
US20090098205A1 (en) * | 2005-09-15 | 2009-04-16 | Council Of Scientife & Industrial Research | pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES |
DK3144013T3 (en) * | 2005-12-01 | 2019-03-04 | Univ Massachusetts Lowell | Botulinum nanoemulsions |
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
WO2007106683A2 (en) * | 2006-03-10 | 2007-09-20 | The Trustees Of The University Of Pennsylvania | Biomimetic iron-oxide-containing lipoprotein and related materials |
JP5292304B2 (ja) * | 2006-12-01 | 2013-09-18 | アンテリオス, インコーポレイテッド | ペプチドナノ粒子およびその使用 |
US20100150994A1 (en) | 2006-12-01 | 2010-06-17 | Anterios, Inc. | Amphiphilic entity nanoparticles |
KR100834687B1 (ko) * | 2007-02-21 | 2008-06-02 | 주식회사 엘지생활건강 | 히노키티올 함유 지질 나노 입자 및 그의 제조방법 |
KR20100050443A (ko) | 2007-05-31 | 2010-05-13 | 안테리오스, 인코퍼레이티드 | 핵산 나노입자 및 이의 용도 |
CN101322719B (zh) * | 2007-06-15 | 2012-03-07 | 杭州民生药业有限公司 | 一种三氧化二砷固体脂质纳米粒及其制剂 |
US8613951B2 (en) * | 2008-06-16 | 2013-12-24 | Bind Therapeutics, Inc. | Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same |
JP2012501966A (ja) | 2008-06-16 | 2012-01-26 | バインド バイオサイエンシズ インコーポレイテッド | ビンカアルカロイド含有治療用ポリマーナノ粒子並びにその製造方法及び使用方法 |
ES2462090T5 (es) | 2008-06-16 | 2017-07-12 | Pfizer Inc. | Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas |
US20110212157A1 (en) * | 2008-06-26 | 2011-09-01 | Anterios, Inc. | Dermal delivery |
US8563041B2 (en) | 2008-12-12 | 2013-10-22 | Bind Therapeutics, Inc. | Therapeutic particles suitable for parenteral administration and methods of making and using same |
ES2776126T3 (es) * | 2008-12-15 | 2020-07-29 | Pfizer | Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos |
EP2266546A1 (en) | 2009-06-08 | 2010-12-29 | Advancell Advanced in Vitro Cell Technologies,S.A. | Process for the preparation of colloidal systems for the delivery of active compounds |
WO2011005769A1 (en) | 2009-07-06 | 2011-01-13 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
WO2011072218A2 (en) | 2009-12-11 | 2011-06-16 | Bind Biosciences | Stable formulations for lyophilizing therapeutic particles |
US9295649B2 (en) | 2009-12-15 | 2016-03-29 | Bind Therapeutics, Inc. | Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
EP2590674B1 (en) | 2010-07-06 | 2017-02-22 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
JP6343147B2 (ja) | 2010-08-30 | 2018-06-13 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 狭窄病変および血栓溶解療法のための剪断による制御放出 |
US10736844B2 (en) | 2011-01-13 | 2020-08-11 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
CN107296792B (zh) * | 2011-01-13 | 2021-07-27 | 变异生物技术公司 | 囊泡及由其产生之制剂的制备方法 |
US20120189677A1 (en) * | 2011-01-20 | 2012-07-26 | Stephen Tonge | Formulations |
DE102011116069A1 (de) | 2011-10-18 | 2013-04-18 | Dr. Rimpler Gmbh | Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung |
AU2013208693B2 (en) | 2012-01-12 | 2017-12-07 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
CA2894467A1 (en) | 2012-01-27 | 2013-08-01 | Variation Biotechnologies Inc. | Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents |
EP2895156B1 (en) | 2012-09-17 | 2019-05-08 | Pfizer Inc. | Process for preparing therapeutic nanoparticles |
WO2014092596A1 (ru) * | 2012-12-12 | 2014-06-19 | Vitkalova Tamara Aleksandrovna | Субстанции и фармацевтические композиции на их основе для лечения заболеваний человека, в том числе, для лечения хронических вирусных гепатитов "в" и "с" |
US9693958B2 (en) * | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
PE20170312A1 (es) | 2014-03-14 | 2017-03-30 | Pfizer | Nanoparticulas terapeuticas que comprenden un agente terapeutico, y metodos para su elaboracion y uso |
WO2015148483A1 (en) * | 2014-03-24 | 2015-10-01 | University Of Mississippi | Systems and methods for preparing solid lipid nanoparticles |
KR102487144B1 (ko) | 2016-11-21 | 2023-01-12 | 에이리온 테라퓨틱스, 인코포레이티드 | 큰 물질의 경피 전달 |
IL267923B2 (en) * | 2018-08-02 | 2023-06-01 | Grifols Worldwide Operations Ltd | The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it |
JP7376582B2 (ja) * | 2018-10-22 | 2023-11-08 | イーオーイー オレオ ゲーエムベーハー | 成形体への圧縮を目的とした粉末材料用添加剤 |
JP2020152673A (ja) | 2019-03-20 | 2020-09-24 | 株式会社リコー | ナノ粒子及びナノ粒子の製造方法、並びに医薬 |
CN111388451B (zh) * | 2020-04-29 | 2023-05-23 | 南京工业大学 | 蛋白自组装铁基纳米粒及其制备方法与抗肿瘤药物递送系统中的应用 |
KR20230088732A (ko) | 2020-09-29 | 2023-06-20 | 옥스포드 유니버시티 이노베이션 리미티드 | 뇌졸중 치료 |
CN113952301A (zh) * | 2021-11-17 | 2022-01-21 | 胡振华 | 中链脂肪酸作为促吸收剂制备药物组合物乳剂的应用 |
DE202023100649U1 (de) | 2023-02-10 | 2023-03-22 | Cineolux Gmbh | Dispersion und Zubereitung zur topischen Anwendung |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2608942B1 (fr) * | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
IE904098A1 (en) * | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
US5665379A (en) * | 1990-09-28 | 1997-09-09 | Pharmacia & Upjohn Aktiebolag | Lipid particle forming matrix, preparation and use thereof |
US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
US6143276A (en) * | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
IT1296914B1 (it) * | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
DE19819273A1 (de) * | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung |
US6967028B2 (en) * | 2000-07-31 | 2005-11-22 | Mainelab | Prolonged release microspheres for injectable administration |
-
2001
- 2001-12-17 IL IL15653101A patent/IL156531A0/xx unknown
- 2001-12-17 AU AU2002226374A patent/AU2002226374B2/en not_active Ceased
- 2001-12-17 EP EP01995691A patent/EP1345597B1/en not_active Expired - Lifetime
- 2001-12-17 CA CA2431888A patent/CA2431888C/en not_active Expired - Fee Related
- 2001-12-17 ES ES01995691T patent/ES2291379T3/es not_active Expired - Lifetime
- 2001-12-17 PT PT01995691T patent/PT1345597E/pt unknown
- 2001-12-17 DE DE60130791T patent/DE60130791T2/de not_active Expired - Lifetime
- 2001-12-17 SI SI200130782T patent/SI1345597T1/sl unknown
- 2001-12-17 JP JP2002552536A patent/JP4072057B2/ja not_active Expired - Fee Related
- 2001-12-17 US US10/451,985 patent/US20040081688A1/en not_active Abandoned
- 2001-12-17 AT AT01995691T patent/ATE374603T1/de active
- 2001-12-17 WO PCT/EP2001/014877 patent/WO2002051390A2/en active IP Right Grant
- 2001-12-17 DK DK01995691T patent/DK1345597T3/da active
- 2001-12-27 AR ARP010106066A patent/AR032073A1/es unknown
-
2003
- 2003-06-19 IL IL156531A patent/IL156531A/en not_active IP Right Cessation
-
2007
- 2007-11-08 CY CY20071101446T patent/CY1106995T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1106995T1 (el) | 2012-09-26 |
AR032073A1 (es) | 2003-10-22 |
CA2431888C (en) | 2010-06-01 |
ATE374603T1 (de) | 2007-10-15 |
WO2002051390A3 (en) | 2002-10-10 |
IL156531A0 (en) | 2004-01-04 |
IL156531A (en) | 2008-11-03 |
AU2002226374B2 (en) | 2006-06-08 |
WO2002051390A2 (en) | 2002-07-04 |
CA2431888A1 (en) | 2002-07-04 |
DE60130791T2 (de) | 2008-07-17 |
DE60130791D1 (de) | 2007-11-15 |
US20040081688A1 (en) | 2004-04-29 |
DK1345597T3 (da) | 2007-12-10 |
EP1345597B1 (en) | 2007-10-03 |
PT1345597E (pt) | 2007-10-29 |
ES2291379T3 (es) | 2008-03-01 |
JP2004519447A (ja) | 2004-07-02 |
JP4072057B2 (ja) | 2008-04-02 |
EP1345597A2 (en) | 2003-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1345597T1 (sl) | Amfifilni lipidni nanodelci za vgradnjo peptidov in/ali proteinov | |
IL160001A0 (en) | Peptide based multimeric targeted contrast agents and methods for the preparation thereof | |
HUP0301003A3 (en) | Casein derived peptides and uses thereof in therapy | |
HUP0202886A3 (en) | Composition comprising casein protein and whey protein | |
GB2369283B (en) | Incorporation of soy proteins in cheese | |
IL153539A0 (en) | Protein complexes and methods for the preparation thereof | |
HUP0300334A3 (en) | Pharmaceutical preparations and their manufacture | |
SI1462455T1 (sl) | Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega | |
AU2001252917A1 (en) | 7 human ovarian and ovarian cancer associated proteins | |
WO2002007671A3 (en) | Intracellular delivery system for protein phosphatases and other polypeptides | |
GB9918155D0 (en) | Proteins and peptides | |
IL147731A0 (en) | Peptide pharmaceutical formulations | |
EP1305331A4 (en) | MOTOR PROTEINS AND METHOD OF USE THEREOF | |
GB0026134D0 (en) | Peptides and their use | |
EP1275657A4 (en) | PEPTIDE DERIVATIVES AND MEDICINAL COMPOSITIONS | |
GB0020952D0 (en) | Genes and proteins and their uses | |
AU2001245367A1 (en) | Human transporter genes and proteins encoded thereby | |
IL135442A0 (en) | Peptides and pharmaceutical compositions comprising them | |
AU2001231917A1 (en) | Isolated complex comprising a nnt-1 protein and in addition at least a clf-1 protein and/or a scntfralpha protein | |
GB0019503D0 (en) | Proteins and their uses | |
GB0000540D0 (en) | Protein and/or peptide based artificial saliva | |
GB0014202D0 (en) | Protein and compositions containing it | |
GB0014208D0 (en) | Protein and compositions containing it | |
GB0014212D0 (en) | Protein and compositions containing it | |
GB0014199D0 (en) | Protein and compositions containing it |